ClinicalTrials.Veeva

Menu

Physical Acvitiy in Pregnancy

University of Maryland Baltimore (UMB) logo

University of Maryland Baltimore (UMB)

Status

Invitation-only

Conditions

Gestational Diabetes
Gestational Diabetes Mellitus in Pregnancy
Pregnant Women
Obese But Otherwise Healthy Participants
Overweight (BMI > 25)

Treatments

Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)

Study type

Observational

Funder types

Other

Identifiers

NCT07356180
HP-00099879

Details and patient eligibility

About

The goal of this observational study is to learn how a physically active lifestyle during pregnancy affects placental development and function. The main question it aims to answer is:

Does regular physical activity during pregnancy improve placental function and support healthy fetal growth?

Pregnant participants will provide biological samples and health information during pregnancy and at delivery. The study will use these samples to examine how activity levels relate to placental energy production and overall health.

Full description

This observational study aims to examine how a physically active lifestyle during pregnancy affects placental function and fetal development. We will enroll pregnant participants and collect biological samples, including blood and placental tissue after delivery. The study will measure markers of placental energy production and other indicators of placental health to understand the mechanisms by which maternal physical activity may influence fetal growth.

Data collected will also include health information, lifestyle questionnaires, and activity assessments during pregnancy. Participants will not need to change their normal exercise habits. The results of this study may help identify how maternal physical activity supports placental and fetal health, which could inform future recommendations for healthy pregnancies.

Enrollment

40 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant female and their newborn infant(s)
  • Aged 18-45 (pregnant female), age 0-60 days of life (newborn infant)
  • English speaking
  • Screened for gestational diabetes with standard glucose tolerance test between 24w - 41w gestation
  • Delivered at gestational age 34week-41weeks
  • Delivered via non-emergent Cesarean section during weekday hours
  • No known infectious disease (ex: HIV, HepC)

Exclusion criteria

  • Women <18yo or >45yo
  • Non-English speaking
  • Pre-existing diabetes or diagnosed with diabetes prior to 24weeks
  • Required complex diets/supplements not related to the pregnancy (i.e. malnutrition)
  • Known severe fetal anomalies or genetic disorder
  • Placenta accreta spectrum
  • Emergent cesarean delivery performed due to fetal distress
  • Known infectious disease (ex: HIV, HepC)

Trial design

40 participants in 4 patient groups

Con
Description:
pre-pregnancy BMI 18.5-24.9, no gestational diabetes
Treatment:
Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)
overweight/obesity group
Description:
pre-pregnancy BMI of 25 or greater, no gestational diabetes
Treatment:
Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)
Gestational DM group
Description:
pre-pregnancy BMI 18.5-24.9 with gestational diabetes
Treatment:
Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)
gestational DM + overweight/obesity group
Description:
pre-pregnancy BMI of 25 or greater, with gestational diabetes
Treatment:
Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems